Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Journal of Geriatric Oncology|May 14, 2020
Caring for older patients with cancer during the COVID-19 pandemic: A Young International Society of Geriatric Oncology (SIOG) global perspectiveIsacco Desideri, Sophie Pilleron, Nicolò Matteo Luca Battisti, et al.
Cancer Medicine|September 26, 2022
Real-world data on lenalidomide dosing and outcomes in patients newly diagnosed with multiple myeloma: Results from the Canadian Myeloma Research Group DatabaseHira Mian, Richard LeBlanc, Martha Louzada, et al.
JNCI Cancer Spectrum|November 25, 2023
Characteristics of post hoc subgroup analyses of oncology clinical trials: a systematic reviewJawad Alrawabdeh, Marah Alzu'bi, Muntaser Alzyoud, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 5, 2022
Survival and Outcomes of Newly Diagnosed Multiple Myeloma Patients Stratified by Transplant Status 2007-2018: Retrospective Analysis from the Canadian Myeloma Research Group DatabaseHira Mian, Donna Reece, Esther Masih-Khan, et al.
Current Oncology (Toronto, Ont.)|March 24, 2022
Sequential Use of Carfilzomib and Pomalidomide in Relapsed Multiple Myeloma: A Report from the Canadian Myeloma Research Group (CMRG) DatabaseArleigh McCurdy, Christopher P Venner, Esther Masih-Khan, et al.
British Journal of Haematology|January 2, 2026
Inconsistent definitions of transplant ineligibility in multiple myeloma: A systematic reviewKarun Neupane, Mitch Singstock, Darshi Shah, et al.
The Oncologist|September 5, 2024
Evaluating early intervention in smoldering myeloma clinical trials: a systematic reviewApoorva Kakkilaya, Aaron Trando, Edward R Scheffer Cliff, et al.
Ejhaem|June 19, 2024
Long-term follow-up of outcomes including progression-free survival 2 in patients with transplant-ineligible multiple myeloma in the real-world practice: A multi-institutional report from the Canadian Myeloma Research Group (CMRG) databaseRayan Kaedbey, Donna Reece, Christopher P Venner, et al.
Ejhaem|December 5, 2022
Carfilzomib usage patterns and outcomes in patients with relapsed multiple myeloma: A multi-institutional report from the Canadian Myeloma Research Group (CMRG) DatabaseArleigh McCurdy, Martha Louzada, Christopher P Venner, et al.
European Journal of Haematology|August 13, 2023
Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysisRichard LeBlanc, Hira Mian, Donna Reece, et al.
Pageof 8